Showing results for "#Cipla"
Dr Reddy’s, Cipla & Aurobindo units recall products in US market
According to the USFDA, Dr Reddy’s Laboratories is recalling the affected lot due to “failed stability specifications”.
Cipla Q1 net profit up 25 pc to Rs 709.92 cr
Drug firm Cipla on Thursday reported a 25.41 per cent increase in its consolidated net profit to Rs 709.92 crore for the quarter ended June 30, 2021,...
Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted...
India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted...
Cipla gets USFDA nod for inhalation product
Drug major Cipla on Wednesday said it has received final approval from the US health regulator for Arformoterol Tartrate Inhalation Solution, used to...
Cipla Gulf, Alvotech expand drug pact to target Australia, NZ
Cipla Gulf FZ LCC is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New...
Cipla to acquire 21.85 pc stake in GoApptiv
Pharma major Cipla on Wednesday said it will acquire 21.85 per cent stake in GoApptiv on a fully-diluted basis in two phases. The cost of acquisition...